The goal of the Clinical Core is to provide clinical resources to facilitate high quality clinical, neuropsychological, epidemiological and neuropathological research in Alzheimer's disease. There are three major operational components in the Clinical Core: 1) A uniform structured baseline clinical evaluation classifies subjects as to the presence or absence of Alzheimer's disease, collects initial psychometric, behavioral and physical function data for comparison with subsequent evaluations to permit measurement of change in these variables, and provides investigators with a uniform and comprehensive description of these variables to ensure a uniform common data set across a wide range of ongoing and future externally funded studies. 2) The branched annual follow-up evaluation was designed to achieve two general purposes. First, to provide a source of well characterized cases and controls with clinical status documented proximate to death to facilitate neuropathological studies. Second, to provide a pool of subjects for studies. 3) To efficiently distribute subjects into clinical, neuropsychological, epidemiological and neuropathological studies, consecutive subjects evaluated by the Core, determined to be eligible for one or more of a variety of externally funded studies will be recruited in a manner which minimizes the burden of studies on patients, their families and staff. To meet these goals, the Clinical Core will build on its successes during the first project period. From March 2, 1992 though August 15, 1995, 1837 persons underwent highly structured uniform clinical evaluations by the Clinical Core. Of these persons, 896 (48.8%) were distributed into in one or more of 20 externally funded studies, including studies requiring large numbers of persons with varying diagnoses across a wide range dementia severity to studies with highly restrictive entry requirements. Minority participation was also high; minorities comprised 18.1% of Clinical Core subjects and 19.2% of study participants.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG010161-07
Application #
6234317
Study Section
Project Start
1997-08-15
Project End
1998-06-30
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
7
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Rush University Medical Center
Department
Type
DUNS #
City
Chicago
State
IL
Country
United States
Zip Code
60612
De Jager, Philip L; Ma, Yiyi; McCabe, Cristin et al. (2018) A multi-omic atlas of the human frontal cortex for aging and Alzheimer's disease research. Sci Data 5:180142
Montagne, Axel; Nikolakopoulou, Angeliki M; Zhao, Zhen et al. (2018) Pericyte degeneration causes white matter dysfunction in the mouse central nervous system. Nat Med 24:326-337
Barnes, Josephine; Bartlett, Jonathan W; Wolk, David A et al. (2018) Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease. J Alzheimers Dis 64:631-642
Dobbyn, Amanda; Huckins, Laura M; Boocock, James et al. (2018) Landscape of Conditional eQTL in Dorsolateral Prefrontal Cortex and Co-localization with Schizophrenia GWAS. Am J Hum Genet 102:1169-1184
Wang, Xulong; Philip, Vivek M; Ananda, Guruprasad et al. (2018) A Bayesian Framework for Generalized Linear Mixed Modeling Identifies New Candidate Loci for Late-Onset Alzheimer's Disease. Genetics 209:51-64
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Chibnik, L B; White, C C; Mukherjee, S et al. (2018) Susceptibility to neurofibrillary tangles: role of the PTPRD locus and limited pleiotropy with other neuropathologies. Mol Psychiatry 23:1521-1529
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872

Showing the most recent 10 out of 786 publications